Podchaser Logo
Home
234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy

234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy

Released Thursday, 10th November 2022
Good episode? Give it some love!
234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy

234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy

234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy

234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy

Thursday, 10th November 2022
Good episode? Give it some love!
Rate Episode

STAT Washington correspondent Sarah Owermohle joins us to explain how this week's midterm elections will affect health and medicine, and what the politicization of the pandemic means for the future of science in the U.S. We also discuss the incoming CEOs of Biogen and Seagen, plus a pair of biotech collapses.

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features